These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 11744470)

  • 61. The significance of abdominal straining in men with lower urinary tract symptoms.
    Reynard JM; Peters TJ; Lamond E; Abrams P
    Br J Urol; 1995 Feb; 75(2):148-53. PubMed ID: 7531591
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Doppler resistive index in benign prostatic hyperplasia: correlation with ultrasonic appearance of the prostate and infravesical obstruction.
    Kojima M; Ochiai A; Naya Y; Okihara K; Ukimura O; Miki T
    Eur Urol; 2000 Apr; 37(4):436-42. PubMed ID: 10765074
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Consequences of prostatic obstruction on bladder function, impact of removal, and management of recurrence after surgery].
    de la Taille A; Robert G; Descazeaud A
    Prog Urol; 2018 Nov; 28(15):813-820. PubMed ID: 30262261
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reasons for the weak correlation between prostate volume and urethral resistance parameters in patients with prostatism.
    Bosch JL; Kranse R; van Mastrigt R; Schröder FH
    J Urol; 1995 Mar; 153(3 Pt 1):689-93. PubMed ID: 7532234
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
    Yang Y; Zhao XF; Li HZ; Wang W; Zhang Y; Xiao H; Zhang X
    Chin Med J (Engl); 2007 Mar; 120(5):370-4. PubMed ID: 17376305
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
    Nickel JC; Elhilali M; Vallancien G;
    BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparative efficacy of two alpha-adrenoreceptor antagonists, doxazosin and alfuzosin, in patients with lower urinary tract symptoms from benign prostatic enlargement.
    de Reijke TM; Klarskov P
    BJU Int; 2004 Apr; 93(6):757-62. PubMed ID: 15049986
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prostatic and extraprostatic alpha-adrenoceptors--contributions to the lower urinary tract symptoms in benign prostatic hyperplasia.
    Andersson KE
    Scand J Urol Nephrol Suppl; 1996; 179():105-11. PubMed ID: 8908675
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The value of symptom score, quality of life score, maximal urinary flow rate, residual volume and prostate size for the diagnosis of obstructive benign prostatic hyperplasia: a urodynamic analysis.
    van Venrooij GE; Boon TA
    J Urol; 1996 Jun; 155(6):2014-8. PubMed ID: 8618311
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Change in parameters before and after alpha-1-blocker therapy for men with lower urinary tract symptoms using color doppler ultrasound urodynamics: possible application for prediction of clinical outcome.
    Watanabe Y; Yokoyama T; Ozawa H; Nishiguchi J; Nose H; Kumon H
    Urol Int; 2004; 73(3):252-7. PubMed ID: 15539846
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Relationship of flow rate with symptoms, quality of life and other clinical parameters in patients with LUTS suggestive of BPH.
    Porru D; Bartoletti R; Austoni E; Carrino M; Gianneo E; Melloni D
    Eur Urol; 2001; 40 Suppl 1():23-7. PubMed ID: 11598350
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of holmium laser enucleation of prostate on overactive bladder symptoms and urodynamic parameters: a prospective study.
    Kwon O; Lee HE; Bae J; Oh JK; Oh SJ
    Urology; 2014 Mar; 83(3):581-5. PubMed ID: 24373317
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Diagnostic values and limitations of conventional urodynamic studies (uroflowmetry.residual urine measurement.cystometry) in benign prostatic hypertrophy].
    Gotoh M; Yoshikawa Y; Kondo A; Kato N; Ono Y; Kondo T; Nagai T; Sakakibara T; Kondo A; Miyake K
    Nihon Hinyokika Gakkai Zasshi; 1996 Dec; 87(12):1321-30. PubMed ID: 8997080
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume.
    Bosch JL; Hop WC; Kirkels WJ; Schröder FH
    Br J Urol; 1995 May; 75(5):622-30. PubMed ID: 7542132
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms.
    Gerber GS; Zagaja GP; Bales GT; Chodak GW; Contreras BA
    Urology; 1998 Jun; 51(6):1003-7. PubMed ID: 9609640
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Correlation between lower urinary tract symptoms and urethral function in benign prostatic hyperplasia.
    Nakai H; Yamanishi T; Yasuda K; Kitahara S; Suzuki T
    Neurourol Urodyn; 2004; 23(7):618-22. PubMed ID: 15382181
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Clinical evaluation of tamsulosin hydrochloride on bladder outlet obstruction associated with benign prostatic hyperplasia: effect on urethral pressure profile and cystometrogram].
    Murayama K; Katsumi T; Tajika E; Kawaguchi K; Ueki O
    Hinyokika Kiyo; 1997 Nov; 43(11):799-803. PubMed ID: 9436025
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
    Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
    J Urol; 2010 Mar; 183(3):1092-7. PubMed ID: 20092847
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Chin PT; Bolton DM; Jack G; Rashid P; Thavaseelan J; Yu RJ; Roehrborn CG; Woo HH
    Urology; 2012 Jan; 79(1):5-11. PubMed ID: 22202539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.